iRhythm Holdings, Inc.
Company Stats
- Market Cap
- $3.7B
- as of Sep 30, 2026
- Shares Outstanding
- 33.0M
- Free Float
- 97.7%
Income Statement
- Revenue
- $747.1M
- Operating Income
- -$57.4M
- Net Income
- -$44.6M
- EBITDA
- -$36.7M
- Non-cash Impairment
- $4.5M
- Revenue Growth, 3Y
- 22.1%
- FCF Margin, 3Y Avg
- -6.3%
- FCF Margin, Worst Year
- -18.4%
Cash Flow
- Free Cash Flow
- $34.5M
- FCF Yield
- 0.9%
- Owner FCF Yield
- -1.4%
Balance Sheet
- Cash & Equivalents
- $236.0M
Returns & Capital
- Buyback Yield, 3Y Avg
- 0.2%
- SBC, 3Y Avg
- $80.5M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $747.1M | $34.5M | 4.6% |
| FY2024 | $591.8M | -$30.6M | -5.2% |
| FY2023 | $492.7M | -$90.5M | -18.4% |
| FY2022 | $410.9M | -$52.8M | -12.9% |
| FY2021 | $322.8M | -$65.8M | -20.4% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 28, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Earnings
Other Coverage
October 5, 2026
Deals
iRhythm to Buy VitalConnect in $287.5 Million Mixed Deal
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back
August 7, 2026
Deals
iRhythm to Buy Vital Connect in $287.5 Million Cardiac-Monitoring Deal
iRhythm to Buy VitalConnect in $287.5 Million Mixed Deal
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back
August 7, 2026
Deals
iRhythm to Buy Vital Connect in $287.5 Million Cardiac-Monitoring Deal